Skip to content
HowShorted

Core Scientific, Inc. short interest in 2025

In 2025, Core Scientific, Inc.'s disclosed short interest ran from 15.20% of shares outstanding on 15 Jan 2025 to 20.10% on 31 Dec 2025, a change of +4.90 percentage points. The year's high was 21.72% on 15 Aug 2025 and its low 13.83% on 14 Mar 2025, averaging 17.60% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.56 days on 15 Dec 2025. Full history: Core Scientific, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2024 · 2025 · 2026

Aggregate net short position time series for Core Scientific, Inc. in 2025

2025 in figures

Start of year
15.20% (15 Jan 2025)
End of year
20.10% (31 Dec 2025)
Change
+4.90 pp
High
21.72% (15 Aug 2025)
Low
13.83% (14 Mar 2025)
Average
17.60%
Highest days to cover
6.56 (15 Dec 2025)
SEC filings marked
8

Every report in 2025

Core Scientific, Inc. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202515.20%4.86
31 Jan 202515.04%2.62
14 Feb 202515.38%6.27
28 Feb 202515.22%3.07results (8-K), 10-K filed
14 Mar 202513.83%1.56
31 Mar 202515.51%2.19
15 Apr 202516.96%2.44
30 Apr 202517.05%4.67
15 May 202515.48%3.7810-Q filed, results (8-K)
30 May 202515.61%3.87
13 Jun 202515.68%4.46
30 Jun 202517.47%2.07
15 Jul 202517.54%1.59
31 Jul 202519.34%4.44
15 Aug 202521.72%3.3210-Q filed, results (8-K)
29 Aug 202518.53%4.28
15 Sep 202518.16%3.83
30 Sep 202520.43%5.65
15 Oct 202519.22%3.48
31 Oct 202519.59%2.9210-Q filed, results (8-K)
14 Nov 202520.59%3.33
28 Nov 202519.12%4.59
15 Dec 202519.68%6.56
31 Dec 202520.10%5.76

See also: Core Scientific, Inc.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.